Outcomes of children with BCR-ABL1-like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease

Roberts, K.Pei, D.Campana, D.Payne-Turner, D.Li, Y.Cheng, C.Sandlund, J.Jeha, S.Easton, J.Becksfort, J.Zhang, J.Coustan-Smith, E.Raimondi, S.Leung, W.Relling, M.Evans, W.Downing, J.Mullighan, C.Pui, C.2017-03-082017-03-082014Journal of Clinical Oncology, 2014; 32(27):3012-30200732-183X1527-7755http://hdl.handle.net/2440/103707Abstract not availableen© 2014 by American Society of Clinical OncologyGene expression profiling; Kaplan-Meier estimate; molecular targeted therapy; percusor cell lymphoblastic leukemia-lymphomaOutcomes of children with BCR-ABL1-like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual diseaseJournal article003006131710.1200/JCO.2014.55.41050003420622000152-s2.0-84907187094277254Mullighan, C. [0000-0002-1871-1850]